Stryker Corporation (SYK)
| Market Cap | 142.31B |
| Revenue (ttm) | 22.60B |
| Net Income (ttm) | 2.99B |
| Shares Out | 381.58M |
| EPS (ttm) | 7.76 |
| PE Ratio | 48.06 |
| Forward PE | 27.68 |
| Dividend | $3.36 (0.90%) |
| Ex-Dividend Date | Mar 31, 2025 |
| Volume | 707,583 |
| Open | 376.26 |
| Previous Close | 374.27 |
| Day's Range | 370.30 - 379.02 |
| 52-Week Range | 314.93 - 406.19 |
| Beta | 0.95 |
| Analysts | Buy |
| Price Target | 420.68 (+12.8%) |
| Earnings Date | Apr 29, 2025 |
About SYK
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke,... [Read more]
Financial Performance
In 2024, Stryker's revenue was $22.60 billion, an increase of 10.23% compared to the previous year's $20.50 billion. Earnings were $2.99 billion, a decrease of -5.43%.
Financial StatementsAnalyst Forecast
According to 20 analysts, the average rating for SYK stock is "Buy." The 12-month stock price forecast is $420.68, which is an increase of 12.80% from the latest price.
News
The Big 3: MMM, PM, SYK
Today's Big 3 focuses on what Dan Deming calls "defensive" plays in a market still exhibiting elevated volatility. He talks about why there's upside potential in 3M (MMM), Philip Morris (PM) and Stryk...
Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting
Latest technology offers more applications and innovation across more specialties MAHWAH, N.J. , March 11, 2025 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, showcases ...
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases
PORTAGE, Mich. , March 6, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System.
Stryker launches Steri-Shield 8 personal protection system
Latest personal protection system offers customizable helmet and three toga choices PORTAGE, Mich. , March 4, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announce...
Stryker launches Sync Badge
Hands-free, wearable communication device supports care team members with fast and reliable collaboration PORTAGE, Mich. , March 3, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical ...
Stryker Corporation (SYK) Citi's 2025 Unplugged Medtech and Life Sciences Access Day (Transcript)
Stryker Corporation (NYSE:SYK) Citi's 2025 Unplugged Medtech and Life Sciences Access Day February 27, 2025 12:15 PM ET Company Participants Preston Wells - CFO Jason Beach - VP, Finance, IR Conferen...
The Big 3: FTNT, NXT, SYK
Dan Deming joins today's Big 3 to talk about three companies he believes may have fallen under the radar for investors. He talks about Fortinet's (FTNT) impact on cybersecurity, Nextracker's (NXT) rol...
Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment
Portage, Michigan, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical, Inc. (NASDAQ:...
Kadant Set to Join S&P SmallCap 600
NEW YORK , Feb. 13, 2025 /PRNewswire/ -- Kadant Inc. (NYSE: KAI) will replace Inari Medical Inc. (NASD: NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 1...
Stryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day
Portage, Michigan, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day on Thursday, February 27, 2025 at Citigroup Headq...
Stryker announces Allan Golston will retire from Board of Directors
Portage, Michigan, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that after 14 years of distinguished service, Allan Golston has notified the company that he will not stand for ...
Sales Growth, Strategic Acquisitions Drive Stryker Higher
Medical device maker Stryker Corporation (SYK) benefits from more procedures, sales, and acquisitions.
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth
Wall Street analysts rerated Stryker Corp SYK Wednesday after the company's fourth-quarter print.
Stryker Corporation (SYK) Q4 2024 Earnings Conference Call Transcript
Stryker Corporation (NYSE:SYK) Q4 2024 Earnings Conference Call January 28, 2025 4:30 PM ET Company Participants Kevin Lobo - Chairman, CEO & President Andy Pierce - Group President of MedSurg & Neur...
Stryker forecasts 2025 profit above estimates on robust demand for surgical devices
Stryker beat Wall Street estimates for fourth-quarter profit and forecast 2025 earnings largely above expectations on Tuesday, fueled by strong demand for its medical and surgical devices.
Overlooked Stock: SYK
Stryker Corp. (SYK) ticked higher after hours after the medical tech company posted an earnings beat. George Tsilis turned to how a rally from this mostly unseen stock reflects the healthcare industry...
Stryker reports 2024 operating results and 2025 outlook
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024:
Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to Vi...
Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that Glenn S. Boehnlein will retire from his role as Vice President, Chief Financial Officer. Boehnlein's decis...
Stryker: A Cool Name For An Awesome Company, But Is It A Buy Ahead Of Earnings?
Stryker Corporation is a high-quality, innovative medical device company with a strong history of revenue, earnings, and FCF growth, driven by R&D and M&A strategies. Shares are currently expensive wi...
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purc...
INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARI
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Inari Medical, I...
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
On Monday, Stryker Corporation SYK agreed to acquire Inari Medical Inc. NARI for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion.
Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion
Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be complementary to its neurovascular business.
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the ...